Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease: A Propensity Score-Adjusted Analysis From the RISPEVA Registry

J Invasive Cardiol.

27 June Jun 2022 one year ago
  • Bartorelli AL
QR Code

The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated.

Reference: Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease: A Propensity Score-Adjusted Analysis From the RISPEVA Registry. Pepe M, Corcione N, Nestola PL, Bedogni F, Berti S, Morello A, Iadanza A, Bartorelli AL, Ferraro P, Spaccarotella C, Sardella G, Cimmino M, Albanese M, De Giosa M, Biondi-Zoccai G, Giordano A. J Invasive Cardiol. 2022 Jun;34(6):E419-E427. Epub 2022 May 6.

Go to PubMed